Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Clinical trial NCT00980655 · COMPLETED

Trial details

NCT number: NCT00980655
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vaccines, Pneumococcal Conjugate Vaccine

Start date: 2010-01-18
Primary completion: 2013-05-16
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.